Moderna Inc (MRNA)

Debt-to-assets ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total assets US$ in thousands 18,426,000 19,450,000 21,884,000 24,125,000 25,858,000 26,056,000 26,043,000 27,609,000 24,669,000 20,923,000 16,153,000 12,694,000 7,337,000 4,650,870 3,486,010 2,067,540 1,589,420 1,590,900 1,685,280 1,806,210
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $18,426,000K
= 0.00

The debt-to-assets ratio of Moderna Inc has remained relatively stable over the past eight quarters, ranging from 0.03 to 0.05. This ratio indicates that, on average, Moderna Inc has very low levels of debt relative to its total assets, with the majority of its assets being financed through equity rather than debt. A low debt-to-assets ratio signifies that the company has a strong financial position and is less reliant on debt to fund its operations and investments. Overall, Moderna Inc's consistent low debt-to-assets ratio suggests a conservative financial strategy and a lower risk of financial distress due to excessive debt burden.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Debt to Assets (Quarterly Data)